{"id":"W4391390283","doi":"10.21037/tcr-23-577","title":"Can we successfully define and target BRCA-like breast cancers?","year":2024,"lang":"en","type":"editorial","venue":"Translational Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; Seagen; Gilead Sciences; Avon Foundation for Women; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Oncology; Medicine; Breast cancer; Internal medicine; Gynecology; Biology; Cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001217088,0.0005334927,0.0008034413,0.0008555941,0.0003169449,0.0001991034,0.0003302288,0.000887365,0.004437887],"category_scores_gemma":[0.00006438153,0.0005041454,0.0002138404,0.001079342,0.0007194569,0.0001494511,0.00007090446,0.003632277,0.0001092088],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001803661,"about_ca_system_score_gemma":0.01167418,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008005361,"about_ca_topic_score_gemma":0.005393378,"domain_scores_codex":[0.9925678,0.000227804,0.0006310561,0.001241671,0.004380822,0.0009508688],"domain_scores_gemma":[0.9963502,0.0009694388,0.0001012112,0.0004938581,0.001568725,0.0005165564],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00173721,0.00005180979,0.0003507974,0.002036742,0.000455688,0.0001176726,0.0005991246,0.00006537583,0.0003848346,0.0004848949,0.9892803,0.004435562],"study_design_scores_gemma":[0.002908337,0.0002230337,0.0003316614,0.00227592,0.0001543536,0.00006384186,0.00004494518,0.0001412045,0.0001707381,0.006299883,0.9869255,0.0004605638],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.001183716,0.1632473,0.00007717362,0.1104625,0.6836987,0.002633055,0.0302412,0.0003610439,0.008095345],"genre_scores_gemma":[0.0178882,0.03640005,0.0004292385,0.0003349672,0.9222912,0.001624493,0.003651972,0.0003675879,0.01701235],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.2385924,"threshold_uncertainty_score":0.999741,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0586367320877046,"score_gpt":0.4245898155582545,"score_spread":0.3659530834705499,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}